ESC Professional Premium Access

Repeat coronary revascularization in high-risk patients treated with ticagrelor monotherapy after PCI: Insights from the randomized TWILIGHT trial

Congress Presentation

About the speaker

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)
53 presentations
12 followers

6 more presentations in this session

Pharmacodynamic and pharmacokinetic profiles associated with switching from cangrelor to prasugrel in patients undergoing percutaneous coronary intervention: the SWAP-6 study

Speaker: Doctor M. Galli (Rome, IT)

Thumbnail

Pattern of dual antiplatelet use and 12-month outcomes stratified by bleeding and ischemic risk in acute coronary syndrome patients undergoing percutaneous coronary intervention

Speaker: Doctor A. Lai (Shatin, HK)

Thumbnail

Mortality with bivalirudin plus a high-dose infusion versus heparin in patients with acute coronary syndrome

Speaker: Doctor M. Galli (Rome, IT)

Thumbnail

In vitro comparison of platelet aggregation between zalunfiban and selatogrel in healthy donors

Speaker: Mr S. Rikken (Nieuwegein, NL)

Thumbnail

Ticagrelor or clopidogrel in atrial fibrillation patients undergoing percutaneous coronary intervention for myocardial infarction

Speaker: Doctor S. Godtfredsen (Aalborg, DK)

Thumbnail

Access the full session

Antithrombotic therapy in acute coronary syndromes and PCI

Speakers: Professor R. Mehran, Doctor M. Galli, Doctor A. Lai, Doctor M. Galli, Mr S. Rikken...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations